US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 30 for "Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,428, issued on Sept. 30, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine" was invented by Fanglong Yang (Shanghai), Xing Fan (Shanghai), Jingjing Yan (Shanghai), Xiqian Zhang (Shanghai), Feng He (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a tricyclic tetrahydroisoquinoline derivative, a preparation method therefor and an application thereof in medicine. In particular, the present disclosur...